Acasti Pharma Releases Preliminary New Animal Data, and Gains Insights Into CaPre’s Novel Mechanism of Action in Diabetes

Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2020

Second Quarter 2020 Earnings Conference Call

Nov 13, 2019 • 1:00 pm EST

2019 Cantor Fitzgerald Global Healthcare Conference

Oct 2, 2019 • 7:45 am EST